Cargando…

Yes-associated protein at the intersection of liver cell fate determination

A recent publication highlights the importance of high yes-associated protein (YAP) expressing cells in liver regeneration following partial hepatectomy. Although the names of the cell populations described in these articles [hybrid periportal hepatocytes (HybHP) or epithelial-mesenchymal transition...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yong-Feng, Wang, Si-Wei, Xu, Zheng-Cai, Zhu, Jin, Zhang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504858/
https://www.ncbi.nlm.nih.gov/pubmed/31114645
http://dx.doi.org/10.4254/wjh.v11.i4.409
_version_ 1783416648620834816
author Bai, Yong-Feng
Wang, Si-Wei
Xu, Zheng-Cai
Zhu, Jin
Zhang, Feng
author_facet Bai, Yong-Feng
Wang, Si-Wei
Xu, Zheng-Cai
Zhu, Jin
Zhang, Feng
author_sort Bai, Yong-Feng
collection PubMed
description A recent publication highlights the importance of high yes-associated protein (YAP) expressing cells in liver regeneration following partial hepatectomy. Although the names of the cell populations described in these articles [hybrid periportal hepatocytes (HybHP) or epithelial-mesenchymal transition (EMT)-reprogrammed hepatocytes] are not identical, they all express high levels of YAP. We hypothesize that the HybHP and EMT-reprogrammed hepatocytes might be a similar cell population. Hippo signaling is the primary pathway that regulates YAP activity. According to the contribution of these two types of cells to liver regeneration and the high YAP expression, Hippo-YAP signaling activation may be a common regulatory pathway experienced by cells undergoing dedifferentiation and reactivating proliferative activity during liver regeneration. Although no evidence has shown that HybHP cells contribute to hepatocellular carcinoma in mouse models, we can not rule out the possibility that these highly regenerative cells can further develop into tumor cells when they acquire mutations caused by viral infection or other risk factors like alcohol. The detailed mechanistic insight of the regulation of YAP expression and activity in HybHP (or other types of cells contributing to liver regeneration) is unknown. We hypothesize that liver regeneration under various conditions will eventually lead to divergent consequences, likely due to the duration of YAP activation regulated by Hippo-large tumor suppressor 1 and 2 pathway in a context- and cell type-dependent manner.
format Online
Article
Text
id pubmed-6504858
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-65048582019-05-21 Yes-associated protein at the intersection of liver cell fate determination Bai, Yong-Feng Wang, Si-Wei Xu, Zheng-Cai Zhu, Jin Zhang, Feng World J Hepatol Letter To The Editor A recent publication highlights the importance of high yes-associated protein (YAP) expressing cells in liver regeneration following partial hepatectomy. Although the names of the cell populations described in these articles [hybrid periportal hepatocytes (HybHP) or epithelial-mesenchymal transition (EMT)-reprogrammed hepatocytes] are not identical, they all express high levels of YAP. We hypothesize that the HybHP and EMT-reprogrammed hepatocytes might be a similar cell population. Hippo signaling is the primary pathway that regulates YAP activity. According to the contribution of these two types of cells to liver regeneration and the high YAP expression, Hippo-YAP signaling activation may be a common regulatory pathway experienced by cells undergoing dedifferentiation and reactivating proliferative activity during liver regeneration. Although no evidence has shown that HybHP cells contribute to hepatocellular carcinoma in mouse models, we can not rule out the possibility that these highly regenerative cells can further develop into tumor cells when they acquire mutations caused by viral infection or other risk factors like alcohol. The detailed mechanistic insight of the regulation of YAP expression and activity in HybHP (or other types of cells contributing to liver regeneration) is unknown. We hypothesize that liver regeneration under various conditions will eventually lead to divergent consequences, likely due to the duration of YAP activation regulated by Hippo-large tumor suppressor 1 and 2 pathway in a context- and cell type-dependent manner. Baishideng Publishing Group Inc 2019-04-27 2019-04-27 /pmc/articles/PMC6504858/ /pubmed/31114645 http://dx.doi.org/10.4254/wjh.v11.i4.409 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letter To The Editor
Bai, Yong-Feng
Wang, Si-Wei
Xu, Zheng-Cai
Zhu, Jin
Zhang, Feng
Yes-associated protein at the intersection of liver cell fate determination
title Yes-associated protein at the intersection of liver cell fate determination
title_full Yes-associated protein at the intersection of liver cell fate determination
title_fullStr Yes-associated protein at the intersection of liver cell fate determination
title_full_unstemmed Yes-associated protein at the intersection of liver cell fate determination
title_short Yes-associated protein at the intersection of liver cell fate determination
title_sort yes-associated protein at the intersection of liver cell fate determination
topic Letter To The Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504858/
https://www.ncbi.nlm.nih.gov/pubmed/31114645
http://dx.doi.org/10.4254/wjh.v11.i4.409
work_keys_str_mv AT baiyongfeng yesassociatedproteinattheintersectionoflivercellfatedetermination
AT wangsiwei yesassociatedproteinattheintersectionoflivercellfatedetermination
AT xuzhengcai yesassociatedproteinattheintersectionoflivercellfatedetermination
AT zhujin yesassociatedproteinattheintersectionoflivercellfatedetermination
AT zhangfeng yesassociatedproteinattheintersectionoflivercellfatedetermination